rs2276101

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001849.4(COL6A2):​c.1817-33C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.052 in 1,611,024 control chromosomes in the GnomAD database, including 5,659 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.066 ( 616 hom., cov: 33)
Exomes 𝑓: 0.050 ( 5043 hom. )

Consequence

COL6A2
NM_001849.4 intron

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -3.74

Publications

6 publications found
Variant links:
Genes affected
COL6A2 (HGNC:2212): (collagen type VI alpha 2 chain) This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]
COL6A2 Gene-Disease associations (from GenCC):
  • collagen 6-related myopathy
    Inheritance: AR, AD, SD Classification: DEFINITIVE Submitted by: ClinGen
  • Ullrich congenital muscular dystrophy 1B
    Inheritance: AR, AD Classification: DEFINITIVE Submitted by: G2P
  • Bethlem myopathy 1A
    Inheritance: AR, AD Classification: STRONG Submitted by: Genomics England PanelApp
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AR, AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myosclerosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001849.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004430741).
BP6
Variant 21-46125432-C-T is Benign according to our data. Variant chr21-46125432-C-T is described in ClinVar as Benign. ClinVar VariationId is 93924.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.334 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001849.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL6A2
NM_001849.4
MANE Select
c.1817-33C>T
intron
N/ANP_001840.3
COL6A2
NM_058174.3
MANE Plus Clinical
c.1817-33C>T
intron
N/ANP_478054.2P12110-2
COL6A2
NM_058175.3
c.1817-33C>T
intron
N/ANP_478055.2P12110-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL6A2
ENST00000300527.9
TSL:1 MANE Select
c.1817-33C>T
intron
N/AENSP00000300527.4P12110-1
COL6A2
ENST00000397763.6
TSL:5 MANE Plus Clinical
c.1817-33C>T
intron
N/AENSP00000380870.1P12110-2
COL6A2
ENST00000413758.1
TSL:3
c.455C>Tp.Pro152Leu
missense
Exon 10 of 11ENSP00000395751.1H7C0M5

Frequencies

GnomAD3 genomes
AF:
0.0663
AC:
10059
AN:
151834
Hom.:
614
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0858
Gnomad AMI
AF:
0.0713
Gnomad AMR
AF:
0.0760
Gnomad ASJ
AF:
0.0401
Gnomad EAS
AF:
0.348
Gnomad SAS
AF:
0.0925
Gnomad FIN
AF:
0.0252
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.0361
Gnomad OTH
AF:
0.0824
GnomAD2 exomes
AF:
0.0753
AC:
18789
AN:
249494
AF XY:
0.0724
show subpopulations
Gnomad AFR exome
AF:
0.0908
Gnomad AMR exome
AF:
0.0896
Gnomad ASJ exome
AF:
0.0347
Gnomad EAS exome
AF:
0.339
Gnomad FIN exome
AF:
0.0257
Gnomad NFE exome
AF:
0.0379
Gnomad OTH exome
AF:
0.0577
GnomAD4 exome
AF:
0.0505
AC:
73631
AN:
1459070
Hom.:
5043
Cov.:
37
AF XY:
0.0512
AC XY:
37190
AN XY:
725804
show subpopulations
African (AFR)
AF:
0.0864
AC:
2888
AN:
33438
American (AMR)
AF:
0.0894
AC:
3994
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.0368
AC:
961
AN:
26090
East Asian (EAS)
AF:
0.408
AC:
16200
AN:
39668
South Asian (SAS)
AF:
0.0788
AC:
6792
AN:
86188
European-Finnish (FIN)
AF:
0.0253
AC:
1317
AN:
52150
Middle Eastern (MID)
AF:
0.0732
AC:
422
AN:
5766
European-Non Finnish (NFE)
AF:
0.0338
AC:
37491
AN:
1110782
Other (OTH)
AF:
0.0591
AC:
3566
AN:
60298
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
3272
6543
9815
13086
16358
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1590
3180
4770
6360
7950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0662
AC:
10063
AN:
151954
Hom.:
616
Cov.:
33
AF XY:
0.0682
AC XY:
5066
AN XY:
74304
show subpopulations
African (AFR)
AF:
0.0856
AC:
3553
AN:
41514
American (AMR)
AF:
0.0759
AC:
1160
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0401
AC:
139
AN:
3466
East Asian (EAS)
AF:
0.348
AC:
1788
AN:
5142
South Asian (SAS)
AF:
0.0924
AC:
445
AN:
4818
European-Finnish (FIN)
AF:
0.0252
AC:
267
AN:
10614
Middle Eastern (MID)
AF:
0.0748
AC:
22
AN:
294
European-Non Finnish (NFE)
AF:
0.0361
AC:
2447
AN:
67798
Other (OTH)
AF:
0.0839
AC:
177
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
441
881
1322
1762
2203
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
108
216
324
432
540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0453
Hom.:
78
Bravo
AF:
0.0731
Asia WGS
AF:
0.169
AC:
587
AN:
3478
EpiCase
AF:
0.0412
EpiControl
AF:
0.0389

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
0.057
DANN
Benign
0.68
DEOGEN2
Benign
0.030
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.0054
N
LIST_S2
Benign
0.29
T
MetaRNN
Benign
0.0044
T
MetaSVM
Benign
-1.0
T
PhyloP100
-3.7
PROVEAN
Benign
-1.2
N
REVEL
Benign
0.096
Sift
Benign
0.13
T
Sift4G
Benign
0.13
T
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2276101;
hg19: chr21-47545346;
COSMIC: COSV56014201;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.